POLARICE

This brand name is authorized in Nigeria.

Active ingredients

The drug POLARICE contains one active pharmaceutical ingredient (API):

1	Menthol UNII L7T10EIP3A - MENTHOL, UNSPECIFIED FORM
	Read more about Menthol

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-100410	Gel	POLARICE GEL GEL 2.5% 1 X 50G	132 NF-PP-313839 POLARICE GEL 2.5% w/w MENTHOL BP 2.5%W/W EACH 50G TUBE CONTAINS MENTHOL BP 2.5 % W/W. GEL BASE QS Drugs Imported Products 1X50G Over The Counter (OTC) 2/9/2023 SUITELIFE PHARMACEUTICAL LIMITED, 4 ayo davis close off ekololu street, surulere, lagos 8129419809 suitelifepharma@yahoo.com GOPALDAS VISRAM & CO. LTD, Plot No A-590/591, MIDC TTC INDUSTRIAL AREA MAHAPE, NAVI MUMBAI - 400 701 MAHARASHTRA INDIA, India	25/05/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
M02AX	Other topical products for joint and muscular pain	M Musculo-skeletal system → M02 Topical products for joint and muscular pain → M02A Topical products for joint and muscular pain
Discover more medicines within M02AX

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-100410